StockNews.com downgraded shares of Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Monday.
MDRX has been the subject of a number of other reports. Zacks Investment Research downgraded shares of Allscripts Healthcare Solutions from a buy rating to a hold rating and set a $23.00 target price for the company. in a report on Tuesday, March 29th. TheStreet upgraded shares of Allscripts Healthcare Solutions from a c+ rating to a b rating in a research note on Friday, February 25th. Piper Sandler boosted their price objective on shares of Allscripts Healthcare Solutions from $19.00 to $22.00 and gave the stock a neutral rating in a research note on Friday, March 18th. SVB Leerink boosted their price objective on shares of Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the stock an outperform rating in a research note on Thursday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Allscripts Healthcare Solutions from a hold rating to a buy rating and boosted their price objective for the stock from $20.00 to $26.00 in a research note on Friday, March 4th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Buy and an average price target of $22.50.
Allscripts Healthcare Solutions stock opened at $20.28 on Monday. Allscripts Healthcare Solutions has a 1 year low of $13.05 and a 1 year high of $23.25. The firm has a 50 day moving average price of $21.69 and a 200 day moving average price of $19.03. The company has a market cap of $2.49 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.68 and a beta of 0.98. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.39 and a current ratio of 1.39.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last released its earnings results on Thursday, February 24th. The software maker reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.47. Allscripts Healthcare Solutions had a net margin of 8.94% and a return on equity of 10.91%. The firm had revenue of $391.70 million during the quarter, compared to the consensus estimate of $390.63 million. During the same period in the previous year, the firm earned $0.24 earnings per share. Allscripts Healthcare Solutions’s revenue was up 1.4% compared to the same quarter last year. Sell-side analysts predict that Allscripts Healthcare Solutions will post 0.75 EPS for the current year.
In related news, CFO Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 15th. The shares were sold at an average price of $20.83, for a total value of $208,300.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Paul Black sold 60,000 shares of the company’s stock in a transaction on Thursday, March 10th. The shares were sold at an average price of $21.87, for a total transaction of $1,312,200.00. The disclosure for this sale can be found here. 1.91% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Brandywine Oak Private Wealth LLC increased its holdings in shares of Allscripts Healthcare Solutions by 15.8% in the 1st quarter. Brandywine Oak Private Wealth LLC now owns 15,027 shares of the software maker’s stock worth $338,000 after acquiring an additional 2,054 shares during the period. Wakefield Asset Management LLLP acquired a new stake in shares of Allscripts Healthcare Solutions in the 1st quarter worth about $857,000. Mutual of America Capital Management LLC increased its holdings in shares of Allscripts Healthcare Solutions by 5.5% in the 1st quarter. Mutual of America Capital Management LLC now owns 17,662 shares of the software maker’s stock worth $398,000 after acquiring an additional 916 shares during the period. Mckinley Capital Management LLC Delaware acquired a new stake in shares of Allscripts Healthcare Solutions in the 1st quarter worth about $4,765,000. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Allscripts Healthcare Solutions by 43.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 11,380 shares of the software maker’s stock worth $256,000 after acquiring an additional 3,470 shares during the period.
About Allscripts Healthcare Solutions (Get Rating)
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.
link